February 2020 Vol 13, Special Issue: Payers' Perspectives in Oncology
Phoebe Starr
Chase Doyle
Chase Doyle
Wayne Kuznar
Wayne Kuznar
First-Line Acalabrutinib-Based Triplet Therapy Leads to Undetectable Minimal Residual Disease in CLL
Wayne Kuznar
Phoebe Starr
Wayne Kuznar